retatrutide 3 receptors vs. Ozempic Retatrutide—A Game Changer in Obesity

Fatigue that persists beyond three to four weeks at the starting dose warrants investigation

So I think the bigger question for the ecosystem and society and for these companies is when those 1.5 million get the notice that they're not going to be able to be accessing their compounded drugs anymore, where are they going to go

Its important to get these individual side effects reported to us, especially for new drugs, so that we can trend it, Ruck said

J., Patel, P., et al

Tirzepatide (Mounjaro/Zepbound) followed the same path

This does not automatically invalidate them, but it means they have not undergone the rigor that clinical trials for pharmaceutical GLP-1 compounds must pass